Astragaloside IV alleviates hypoxia/reoxygenation-induced neonatal rat cardiomyocyte injury via the protein kinase a pathway

Pharmacology

Volumn 90, Issue 1-2, 2012, Pages 95-101

  Zhang, Da Wei ^a   Bian, Zhi Ping ^a   Xu, Jin Dan ^a   Wu, Heng Fang ^a   Gu, Chun Rong ^a   Zhou, Bin ^a,b   Chen, Xiang Jian ^a   Yang, Di ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Astragaloside IV; Cardioprotection; Hypoxia Reoxygenation; Phospholamban; Protein kinase A; Sarcoplasmic reticulum calcium ATPase

Indexed keywords

ASTRAGALOSIDE IV; CREATINE KINASE MB; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT; CYCLIC AMP DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA; CYCLIC AMP DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT BETA; CYCLIC AMP DEPENDENT PROTEIN KINASE REGULATORY SUBUNIT IALPHA; CYCLIC AMP DEPENDENT PROTEIN KINASE REGULATORY SUBUNIT IIALPHA; CYCLIC AMP DEPENDENT PROTEIN KINASE REGULATORY SUBUNIT IIBETA; MESSENGER RNA; PHOSPHOLAMBAN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SERINE 16 PHOSPHORYLATED PHOSPHOLAMBAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL HYPOXIA; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INDUCTION; ENZYME RELEASE; ENZYME SUBUNIT; GENE EXPRESSION REGULATION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REOXYGENATION; REPERFUSION INJURY; SUPERNATANT; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; CARDIOTONIC AGENTS; CELL HYPOXIA; CELLS, CULTURED; CREATINE KINASE, MB FORM; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GENE EXPRESSION; MYOCYTES, CARDIAC; PROTEIN SUBUNITS; RATS; REPERFUSION INJURY; RNA, MESSENGER; SAPONINS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; TRITERPENES;

EID: 84863729951     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000339476     Document Type: Article

References (22)

1. 2+-ATPase in failing and nonfailing human myocardium. Circ Res 1994;75:434-442.
2. Gupta D, Palma J, Molina E, Gaughan J P, Long W, Houser S, Macha M: Improved exercise capacity and reduced systemic inflammation after adenoviral-mediated SER-CA-2a gene transfer. J Surg Res 2008;145: 257-265.
3. 2+-ATPase gene transfer in a heart failure model induced by chronic myocardial ischaemia. Acta Cardiol 2011;66:57-64.
4. 2+ AT Pase pump expression and its relevance to cardiac muscle physiology and pathology. Car-diovasc Res 2008;77:265-273.
5. 17 in cardiac physiological and pathological conditions. Cardiovasc Res 2005;68:366-375.
6. 17 residue of phospholamban as a phosphorylation site under physiological and pathological conditions. Braz J Med Biol Res 2006;39:563-572.
7. Simmerman H, Collins J, Theibert J, Wegen-er A, Jones L: Sequence analysis of phosphol-amban. Identification of phosphorylation sites and two major structural domains. J Biol Chem 1986;261:13333-13341.
8. Wegener A, Simmerman H, Lindemann J, Jones L: Phospholamban phosphorylation in intact ventricles. Phosphorylation of serine 16 and threonine 17 in response to beta-ad-renergic stimulation. J Biol Chem 1989;264: 11468-11474.
9. Sande JB, Sjaastad I, Hoen IB, Bøkenes J, Tønnessen T, Holt E, Lunde PK, Christensen G: Reduced level of serine(16) phosphory-lated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity. Cardiovasc Res 2002;53: 382-391.
10. Chen X, Meng D, Feng L, Bian Y, Li P, Yang D, Cao K, Zhang J: Protective effect of as-tragalosides on myocardial injury by isopro-terenol in SD rats. Am J Chin Med 2006;34: 1015-1025.
11. Zhang W, Chen H, Zhang C, Liu R, Li H: Astragaloside IV from Astragalus membra-naceus shows cardioprotection during myo-cardial ischemia in vivo and in vitro. Planta Med 2006;72:4-8.
12. Shi H, Ma C, Liu Y, Zhou J, Hu Z, Wu D: Inhibitory effect on activated renin-angiotensin system by astragaloside IV in rats with pressure-overload induced cardiac hypertrophy (in Chinese). Zhongguo Zhong Yao Za Zhi 2009;34:3242-3246.
13. 2+-ATPase. Pharmacology 2008;81:325-332.
14. Chlopcíková S, Psotová J, Miketová P: Neonatal rat cardiomyocytes-a model for the study of morphological, biochemical and electrophysiological characteristics of the heart. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2001;145:49-55.
15. Ajmani P, Yadav H, Singh M, Sharam P: Possible involvement of coveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart. BMC Cardiovasc Disord 2011;11:43-52.
16. 2+-dependent pNPPase. Age-dependent changes. Basic Res Cardiol 1995;90:323-331.
17. Cohen J, Resnick D, Niewiadomski P, Dong H, Liau L, Waschek J: Pituitary adenylyl cy-clase activating polypeptide inhibits gli1 gene expression and proliferation in primary me-dulloblastoma derived tumorsphere cultures. BMC Cancer 2010;10:676-683.
18. Kohr MJ, Wang H, Wheeler DG, Vela-yutham M, Zweier JL, Ziolo MT: Targeting of phospholamban by peroxynitrite decreases β-adrenergic stimulation in cardiomyocytes. Cardiovasc Res 2008;77:353-361.
19. Cheng X, Ji Z, Tsalkova T, Mei F: Epac and PKA: a tale of two intracellular cAMP receptors. Acta Biochim Biophys Sin (Shanghai) 2008;40:651-662.
20. Tang WH, Kravtsov GM, Sauert M, Tong XY, Hou XY, Wong TM, Chung SK, Man Chung SS: Polyol pathway impairs the function of SERCA and RyR in ischemic-reperfused rat hearts by increasing oxidative modifications of these proteins. J Mol Cell Cardiol 2010;49:58-69.
21. Xiao JF, Wang CY, Huang YP, Shen JX, Gao FF, Huang ZQ, Zheng YS, Shi GG: N-n-bu-tyl haloperidol iodide preserves cardiomyo-cyte calcium homeostasis during hypoxia/ischemia. Cell Physiol Biochem 2011;27: 433-442.
22. Xu X, Ji H, Gu S, Shao Q, Huang Q, Cheng Y: Cardioprotective effects of astragali radix against isoproterenol-induced myocardial injury in rats and its possible mechanism. Phytother Res 2008;22:389-394.